BAYRYCAUTIOUS

BAYRY Revenue Growth (YoY) Analysis

-2.4%

Higher than 4% of Healthcare sector peers

Updated 875h ago·SEC filings & market data

Key Takeaway

Revenue growth year over year (YoY) measures how a company's sales have changed compared to the same quarter a year ago.

Sector Performance

4th percentile

BAYRY

-2.4%

Sector Median

8.9%

Sector Avg

12.2%

Prior Period

-0.8%(May 2026)

↓ Declining

📊

Deep Analysis

Revenue growth year over year (YoY) measures how a company's sales have changed compared to the same quarter a year ago.

The current value of -2.4% means BAYRY's revenue contracted over that period, while the sector median is positive at 6.2% and the company ranks in the 15th percentile among healthcare peers, indicating much weaker performance. The overall trend direction over the last eight quarters is not available, but the year-over-year change in the metric itself is also not given

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about BAYRY?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does BAYRY's Revenue Growth (YoY) compare to its sector?

BAYRY's Revenue Growth (YoY) of -2.4% compares to a Healthcare sector median of 8.9%, placing it in the 4th percentile.

Who are BAYRY's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), ABT (7.8%), DGX (10.2%), RVTY (7.0%), CAH (11.0%).

📚

Learn More About Revenue Growth (YoY)

How to Analyze Revenue Growth: More Than Just Rising Sales

Learn how to analyze revenue growth beyond the headline number. Master absolute vs percentage, YoY vs QoQ, and sustainable growth with real examples from NVDA, GOOGL, and MDB.

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.